pyrroles has been researched along with Memory Disorders in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 6 (30.00) | 29.6817 |
| 2010's | 12 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dehpour, AR; Honarmand, AR; Javadi-Paydar, M; Pourtabatabaei, N; Rahimi, N | 1 |
| Fan, Q; Hou, Y; Li, H; Nie, W; Sun, R; Wang, A; Yu, Z | 1 |
| Jin, Y; Liang, B; Qu, WH; Sui, HJ; Wang, HM; Yu, SX; Zhang, LL | 1 |
| Darras, FH; Decker, M; Khan, N; Nurulain, SM; Saad, A; Sadek, B | 1 |
| Feng, X; Gupta, N; Jopson, TD; Liu, S; Paladini, MS; Rosi, S; West, BL | 1 |
| Bezerra, SC; de Bem, AF; Duarte, FS; Figueiredo, CP; Mancini, G; Piermartiri, TC; Prediger, RD; Rial, D; Tasca, CI | 1 |
| Akgün-Dar, K; Aksu, U; Uzüm, G | 1 |
| Bouwels, L; de Leeuw, FE; Enajat, M; Pop, G; Pop-Purceleanu, M; Tendolkar, I; van Kuilenburg, J; van Wingen, G; Zwiers, MP | 1 |
| Dehpour, AR; Fakhraei, N; Javadi-Paydar, M; Mirazi, N; Norouzi, A; Rayatnia, F; Zakeri, M | 1 |
| Allami, N; Dehpour, AR; Javadi-Paydar, M; Norouzi, A; Rastegar, H; Rayatnia, F; Zakeri, M | 1 |
| Bink, DI; Breuer, ME; Douma, TN; Hendriksen, H; Meulendijks, D; Olivier, B; Oosting, RS; Westphal, KG | 1 |
| Hennessey, MJ; Murphy, SM; Ryan, D | 1 |
| Birthelmer, A; Cassel, JC; Jackisch, R; Stemmelin, J | 1 |
| Birthelmer, A; Cassel, JC; Jackisch, R; Lazaris, A; Schweizer, T | 1 |
| Harrell, TK; Jones, DW; King, DS; Lindley, BJ; Wilburn, AJ; Wofford, MR | 1 |
| Khan, S; Plamondon, H | 1 |
| Chen, J; Chopp, M; Goussev, A; Jiang, H; Li, Y; Lu, C; Lu, D; Mahmood, A; Qu, C; Schallert, T | 1 |
| Buhot, MC; Naïli, S; Patra, SK | 1 |
| Lazarova-Bakarova, MB; Petkov, VD; Petkova, BP; Todorov, IK | 1 |
1 trial(s) available for pyrroles and Memory Disorders
| Article | Year |
|---|---|
One-year cholesterol lowering treatment reduces medial temporal lobe atrophy and memory decline in stroke-free elderly with atrial fibrillation: evidence from a parallel group randomized trial.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Anticholesteremic Agents; Anticoagulants; Atorvastatin; Atrial Fibrillation; Atrophy; Azetidines; Biomarkers; Cholesterol; Double-Blind Method; Ezetimibe; Female; Heptanoic Acids; Humans; Male; Memory; Memory Disorders; Neuropsychological Tests; Pyrroles; Temporal Lobe | 2012 |
19 other study(ies) available for pyrroles and Memory Disorders
| Article | Year |
|---|---|
Suppression of memory acquisition following co-administration of lithium and atorvastatin through nitric oxide pathway in mice.
Topics: Animals; Atorvastatin; Avoidance Learning; Dose-Response Relationship, Drug; Heptanoic Acids; Lithium; Male; Memory; Memory Disorders; Mice; Nitric Oxide; Pyrroles; Signal Transduction | 2014 |
Epigenetic upregulation of corticotrophin-releasing hormone mediates postnatal maternal separation-induced memory deficiency.
Topics: Acetylation; Animals; Animals, Newborn; Corticotropin-Releasing Hormone; Electric Stimulation; Epigenesis, Genetic; Hippocampus; Histones; Long-Term Potentiation; Maternal Deprivation; Maze Learning; Memory Disorders; Methyl-CpG-Binding Protein 2; Neuronal Plasticity; Phosphorylation; Promoter Regions, Genetic; Pyrimidines; Pyrroles; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; RNA, Messenger; Up-Regulation | 2014 |
Atorvastatin prevents amyloid-β peptide oligomer-induced synaptotoxicity and memory dysfunction in rats through a p38 MAPK-dependent pathway.
Topics: Amyloid beta-Peptides; Animals; Anticholesteremic Agents; Atorvastatin; Cells, Cultured; Heptanoic Acids; Hippocampus; Male; Maze Learning; Memory Disorders; Neurons; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Pyrroles; Rats; Rats, Sprague-Dawley; Signal Transduction; Synapses | 2014 |
The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in rats.
Topics: Animals; Avoidance Learning; Benzothiazoles; Cholinesterase Inhibitors; Disease Models, Animal; Dizocilpine Maleate; Donepezil; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Histamine H3 Antagonists; Indans; Male; Memory; Memory Disorders; Nootropic Agents; Phenoxypropanolamines; Piperidines; Pyrilamine; Pyrroles; Quinazolines; Random Allocation; Rats, Wistar; Receptors, Histamine H3 | 2016 |
Colony-stimulating factor 1 receptor blockade prevents fractionated whole-brain irradiation-induced memory deficits.
Topics: Aminopyridines; Animals; Brain; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pyrroles; Radiation Effects; Receptor, Macrophage Colony-Stimulating Factor | 2016 |
Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage.
Topics: Amino Acid Transport System X-AG; Amyloid beta-Peptides; Analysis of Variance; Animals; Animals, Newborn; Astrocytes; Atorvastatin; Cell Death; Cyclooxygenase 2; Encephalitis; Fluoresceins; Gene Expression Regulation; Glutamic Acid; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Heptanoic Acids; Hippocampus; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Learning Disabilities; Male; Maze Learning; Memory Disorders; Mice; Nerve Tissue Proteins; Neurons; Organic Chemicals; Oxidative Stress; Peptide Fragments; Propidium; Pyrroles; Tritium | 2010 |
The effects of atorvastatin on memory deficit and seizure susceptibility in pentylentetrazole-kindled rats.
Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Atorvastatin; Avoidance Learning; Disease Susceptibility; Electroencephalography; Heptanoic Acids; Kindling, Neurologic; Male; Memory Disorders; Pentylenetetrazole; Pyrroles; Rats; Rats, Wistar; Reaction Time; Seizures | 2010 |
Atorvastatin improved scopolamine-induced impairment in memory acquisition in mice: involvement of nitric oxide.
Topics: Animals; Arginine; Atorvastatin; Cholinergic Antagonists; Disease Models, Animal; Enzyme Inhibitors; Guanidines; Heptanoic Acids; Learning Disabilities; Memory; Memory Disorders; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pyrroles; Scopolamine | 2011 |
Nitric oxide involvement in consolidation, but not retrieval phase of cognitive performance enhanced by atorvastatin in mice.
Topics: Animals; Arginine; Atorvastatin; Cognition; Drug Antagonism; Drug Synergism; Guanidines; Heptanoic Acids; Memory; Memory Disorders; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pyrroles; Scopolamine; Spatial Behavior | 2011 |
Environmental enrichment has antidepressant-like action without improving learning and memory deficits in olfactory bulbectomized rats.
Topics: Analysis of Variance; Animals; Avoidance Learning; Body Weight; Brain-Derived Neurotrophic Factor; Depression; Disease Models, Animal; Environment; Exercise Therapy; Exploratory Behavior; Indoles; Learning Disabilities; Locomotion; Maze Learning; Memory Disorders; Olfactory Bulb; Protein Kinase Inhibitors; Pyrroles; Rats; Rats, Sprague-Dawley; Recognition, Psychology; RNA, Messenger; Time Factors; Vascular Endothelial Growth Factor A | 2012 |
Bilateral posterior cerebral artery infarction.
Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Confusion; Dominance, Cerebral; Drug Therapy, Combination; Fibrinolytic Agents; Hemianopsia; Heptanoic Acids; Humans; Infarction, Posterior Cerebral Artery; Magnetic Resonance Imaging; Male; Memory Disorders; Memory, Short-Term; Perindopril; Pyrroles; Tomography, X-Ray Computed | 2010 |
Presynaptic modulation of acetylcholine, noradrenaline, and serotonin release in the hippocampus of aged rats with various levels of memory impairments.
Topics: Acetylcholine; Acetylcholinesterase; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aging; Analysis of Variance; Animals; Behavior, Animal; Brimonidine Tartrate; Choline O-Acetyltransferase; Female; Hippocampus; Idazoxan; In Vitro Techniques; Maze Learning; Memory Disorders; Methiothepin; Muscarinic Agonists; Norepinephrine; Oxotremorine; Presynaptic Terminals; Pyridines; Pyrroles; Quinoxalines; Rats; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming; Tritium | 2003 |
Presynaptic regulation of neurotransmitter release in the cortex of aged rats with differential memory impairments.
Topics: Acetylcholine; Acetylcholinesterase; Adrenergic alpha-Agonists; Aging; Animals; Brimonidine Tartrate; Cerebral Cortex; Choline; Choline O-Acetyltransferase; Chromatography, High Pressure Liquid; Electric Stimulation; Female; Maze Learning; Memory Disorders; Muscarinic Agonists; Neurotransmitter Agents; Norepinephrine; Oxotremorine; Pyridines; Pyrroles; Quinoxalines; Rats; Rats, Long-Evans; Receptors, Presynaptic; Serotonin; Serotonin Receptor Agonists | 2003 |
Cognitive impairment associated with atorvastatin and simvastatin.
Topics: Aged; Atorvastatin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Memory Disorders; Pyrroles; Simvastatin | 2003 |
The CRH1 antagonist CP154,526 failed to alter ischemia-induced neurodegeneration and spatial memory deficits in rats but inhibited behavioral activity in the novel open field.
Topics: Animals; Behavior, Animal; Cell Count; Dose-Response Relationship, Drug; Exploratory Behavior; Hippocampus; Ischemia; Male; Memory Disorders; Nerve Degeneration; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Spatial Behavior; Time Factors | 2006 |
Statins don't stop aortic valve narrowing...or memory loss (yet).
Topics: Aortic Valve Stenosis; Atorvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Memory Disorders; Pyrroles; Treatment Failure | 2005 |
Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury.
Topics: Animals; Atorvastatin; Brain Injuries; Cell Proliferation; Dentate Gyrus; Dose-Response Relationship, Drug; Heptanoic Acids; Hippocampus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Maze Learning; Memory Disorders; Neovascularization, Physiologic; Nerve Degeneration; Nerve Regeneration; Neuronal Plasticity; Neurons; Neuroprotective Agents; Pyrroles; Rats; Rats, Wistar; Recovery of Function; Simvastatin; Stem Cells; Treatment Outcome | 2007 |
Spatial memory deficits following stimulation of hippocampal 5-HT1B receptors in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Handling, Psychological; Hippocampus; Injections; Male; Maze Learning; Memory Disorders; Memory, Short-Term; Muscarinic Antagonists; Pyridines; Pyrroles; Rats; Receptors, Serotonin; Scopolamine; Serotonin Receptor Agonists; Space Perception | 1995 |
Memory impairment induced by combined disturbance of noradrenergic and dopaminergic neurotransmissions: effects of nootropic drugs.
Topics: Animals; Avoidance Learning; Benzoates; Central Nervous System Agents; Clonidine; Dopamine; Haloperidol; Male; Meclofenoxate; Memory Disorders; Norepinephrine; Punishment; Pyrroles; Rats; Rats, Inbred Strains; Synaptic Transmission | 1991 |